“BINGO" game helps researchers study perception deficits

 

Cleveland, Ohio, USA (January 3, 2012) – Bingo, a popular activity in nursing homes, senior centers and assisted-living facilities, has benefits that extend well beyond socializing. Researchers found high-contrast, large bingo cards boost thinking and playing skills for people with cognitive difficulties and visual perception problems produced by Alzheimer’s disease (AD) and Parkinson’s disease (PD).

 

“The general finding of improved performance across healthy and afflicted groups suggests the value of visual support as an easy-to-apply intervention to enhance cognitive performance,” researchers from Case Western Reserve University, Boston University and Bridgewater State University wrote.

 

The findings were reported in the article, “Bingo! Externally supported performance intervention for deficit visual search in normal aging, Parkinson’s disease, and Alzheimer’s disease,” in the journal Aging, Neuropsychology, and Cognition.

 

As people age, they begin to lose sensitivity to perceive contrasts. It is exacerbated in people with dementia, according to Grover C. Gilmore, a psychologist and dean of the Mandel School of Applied Social Sciences at Case Western Reserve University.

 

Bingo is often used in nursing homes and senior centers as a social activity, and being socially engaged helps keep the mind healthy.

 

But little is known about how visual perception problems—common in aging players—affect the way these people think and play, said Gilmore, who has done extensive testing in his Perception Lab at Case Western Reserve.

 

Researchers tested cards of different sizes, contrasts and visual complexities to find out how visual perception problems impact cognitive functions among the study’s participants: 19 younger adults, 14 individuals with probable AD, 13 AD-matched healthy adults, 17 non-demented individuals with Parkinson’s disease and 20 PD-matched healthy adults.

 

When study participants played bingo on computer-generated cards that were manipulated for brightness, size and contrast, the researchers could compare the performance among the different age and health groups.

 

With some contrast and size changes to the card, researchers reported improvement in performances. For those with mild dementia, they could perform at levels of their healthy peers. Little change was reported for people with more severe dementia.

 

Gilmore and the study’s lead investigator, Alice Cronin-Golomb from Boston University, have collaborated for two decades on projects that look at visual sensory deficits and cognition among people with dementia. For PD individuals, driving is affected by low contrasts as demonstrated in simulated fog situations.

 

They have found that boosting contrast in the living environment and also at the table enables people with dementia—who have lost the ability to distinguish between similar-contrast objects—to move safely around their homes and improve their eating.

 

For example, putting a black sofa in a white room would improve the contrast of the room and make it easier for individuals to move about. Additionally, they found that individuals with dementia actually eat more if they use a white plate and tableware on a dark tablecloth or are served food that contrasts the color of the plate.

 

Boosting contrast is among interventions known as Externally Supported Performance Interventions (ESPI). The researchers say these interventions allow people with dementia and others with visual perception deficits to live independently longer, perform daily tasks and enjoy life and having such pleasures as reading a book.

 

  • Other contributors to the study are: Boston University researchers Thomas M. Laudate, Sandy Neargarder (also from Bridgewater), Tracy E. Dunne, Karen D. Sullivan and Pallavi Joshi and Case Western Reserve University researcher Tatiana M. Riedel.

 


 

Case Western Reserve University, 03.01.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…